Showing results (81-90 of 439) with videos related to
Sort By:
Pageof 44
Expert Review of Hematology|October 28, 2022
From bench to bedside: bridging the gaps in best practices for real-world chronic myeloid leukemia careGiovanni Manfredi Assanto, Emilia Scalzulli, Ida Carmosino, et al.Journal of Hematology & Oncology|July 11, 2022
A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phaseValentin García-Gutiérrez, Massimo Breccia, Elias Jabbour, et al.Haematologica|July 20, 2004
Prognostic factors in myelodysplastic and myeloproliferative types of chronic myelomonocytic leukemia: a retrospective analysis of 83 patients from a single institutionMassimo Breccia, Roberto Latagliata, Andrea Mengarelli, et al.Haematologica|October 18, 2006
Identification of risk factors in atypical chronic myeloid leukemiaMassimo Breccia, Francesca Biondo, Roberto Latagliata, et al.JMIR Research Protocols|April 23, 2021
The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational StudyFabio Efficace, Massimo Breccia, Paola Fazi, et al.Frontiers in Cell and Developmental Biology|March 16, 2026
Molecular characterization of pediatric mastocytosis revealed different somatic mutations with uncertain prognostic valueDeborah Kasmi, Fiorina Giona, Michela Ribersani, et al.Expert Review of Hematology|June 14, 2021
Health-related quality of life in patients with acute promyelocytic leukemia: a systematic literature reviewFabio Efficace, Laura Cannella, Massimo Breccia, et al.Clinical Lymphoma, Myeloma & Leukemia|April 7, 2023
Management of Chronic Myeloid Leukemia Patients in Later Lines: The Role of Ponatinib and New CompoundsEmilia Scalzulli, Ida Carmosino, Alessandro Costa, et al.Seminars in Oncology|November 22, 2019
Mechanisms and clinical course of cardiovascular toxicity of cancer treatment II. Hematology☆Massimo Breccia, Joseph R Carver, Sebastian Szmit, et al.Oncology and Therapy|January 17, 2025
Red Blood Cell Distribution Width May Predict Drug-Induced Anemia and Prognosis in Patients Affected by Primary/Secondary Myelofibrosis Treated with RuxolitinibAlessandro Laganà, Emilia Scalzulli, Ida Carmosino, et al.Pageof 44